The BC Bud Co Appoints Cary Alexander to Advisory Board

In This Article:

Vancouver, British Columbia--(Newsfile Corp. - May 14, 2024) - The BC Bud Corporation (CSE: BCBC) (OTCQB: BCBCF) ("The BC Bud Co" or the "Company"), a house of high-quality cannabis brands based out of British Columbia, Canada, is pleased to announce the addition of Cary Alexander to its advisory board.

After obtaining a finance degree from the University of Texas, Cary relocated to Los Angeles and pursued a career as an actor and executive producer. During this time, he became involved with startups in the rapidly growing cannabis and plant science sectors. Cary played a key role in financing, developing, and expanding successful cannabis brands such as Jeeter, Bloom, Packwoods, and Tyson 2.0.

Cary has been actively involved in financing and developing cannabis assets, showcasing his deep understanding of the regulatory and operational intricacies of the industry. Furthermore, his involvement in orchestrating multiple mergers and acquisitions highlights his expertise in deal-making within the cannabis sector.

"I'm thrilled to join this distinguished team of cannabis and capital market experts. Our collaboration comes at an opportune time amidst the evolving cannabis landscape. With more states and countries legalizing cannabis, we're witnessing a paradigm shift, offering immense promise for industry growth.

Recent developments in Germany, Spain, and across half of the US, along with initiatives in countries like Thailand, highlight the global awakening to cannabis's potential in both recreational and medicinal spheres.

In this dynamic environment, BCBC stands poised for unparalleled success. Our management and advisory board bring unmatched industry insights and an extensive network across legal markets.

Our aspirations transcend borders. We're actively seeking promising American brands with global recognition potential to introduce new product categories. Leveraging industry insights and a wide network, we identify opportunities for consolidation and optimization. Our goal is to position BCBC as a comprehensive provider with a diverse portfolio, including American brands with global potential to tap into new markets," stated Mr. Alexander.

At this time, the Company has not commenced any operations in the United States, nor identified specific acquisition or partner transactions. Despite recent steps by the DEA to reclassify cannabis as a Schedule III controlled substance, it remains classified as a Schedule I drug under the Controlled Substances Act and is federally prohibited for cultivation, use, and sale.